87 related articles for article (PubMed ID: 12858231)
1. Polymorphisms of SLCO1B1 rs4149056 and SLC22A1 rs2282143 are associated with responsiveness to acitretin in psoriasis patients.
Chen W; Zhang X; Zhang W; Peng C; Zhu W; Chen X
Sci Rep; 2018 Sep; 8(1):13182. PubMed ID: 30181619
[TBL] [Abstract][Full Text] [Related]
2. A review of acitretin for the treatment of psoriasis.
Lee CS; Li K
Expert Opin Drug Saf; 2009 Nov; 8(6):769-79. PubMed ID: 19998529
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of acitretin in three fixed doses of 25, 35 and 50 mg in adult patients with severe plaque type psoriasis: a randomized, double blind, parallel group, dose ranging study.
Dogra S; Jain A; Kanwar AJ
J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e305-11. PubMed ID: 22816881
[TBL] [Abstract][Full Text] [Related]
4. Acitretin in dermatology: a review.
Dunn LK; Gaar LR; Yentzer BA; O'Neill JL; Feldman SR
J Drugs Dermatol; 2011 Jul; 10(7):772-82. PubMed ID: 21720660
[TBL] [Abstract][Full Text] [Related]
5. Psoriatic Resolved Skin Epidermal Keratinocytes Retain Disease-Residual Transcriptomic and Epigenomic Profiles.
Ghaffarinia A; Ayaydin F; Póliska S; Manczinger M; Bolla BS; Flink LB; Balogh F; Veréb Z; Bozó R; Szabó K; Bata-Csörgő Z; Kemény L
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901987
[TBL] [Abstract][Full Text] [Related]
6. Psoriatic disease and non-alcoholic fatty liver disease shared pathogenesis review.
Torosian K; Lal E; Kavanaugh A; Loomba R; Ajmera V; Guma M
Semin Arthritis Rheum; 2023 Apr; 59():152165. PubMed ID: 36716599
[TBL] [Abstract][Full Text] [Related]
7. Current and Future Therapies for Psoriasis with a Focus on Serotonergic Drugs.
Martins AM; Ascenso A; Ribeiro HM; Marto J
Mol Neurobiol; 2020 May; 57(5):2391-2419. PubMed ID: 32062841
[TBL] [Abstract][Full Text] [Related]
8. Calcipotriol and betamethasone dipropionate in the treatment of mild-to-moderate psoriasis: a cost-effectiveness analysis of the ointment versus gel formulation.
Colombo GL; Di Matteo S; Bruno G; Girolomoni G; Vena GA
Clinicoecon Outcomes Res; 2012; 4():261-8. PubMed ID: 23028233
[TBL] [Abstract][Full Text] [Related]
9. Increasing the intracellular availability of all-trans retinoic acid in neuroblastoma cells.
Armstrong JL; Ruiz M; Boddy AV; Redfern CP; Pearson AD; Veal GJ
Br J Cancer; 2005 Feb; 92(4):696-704. PubMed ID: 15714209
[TBL] [Abstract][Full Text] [Related]
10. Advances in psoriasis therapy.
Koo J; Nguyen Q; Gambla C
Adv Dermatol; 1997; 12():47-72; discussion 73. PubMed ID: 8973735
[No Abstract] [Full Text] [Related]
11. An updated review of acitretin--a systemic retinoid for the treatment of psoriasis.
Pang ML; Murase JE; Koo J
Expert Opin Drug Metab Toxicol; 2008 Jul; 4(7):953-64. PubMed ID: 18624682
[TBL] [Abstract][Full Text] [Related]
12. [Patient memo. Advice for patients with psoriasis and using Soriatane].
Rev Prat; 2004 Jan; 54(1):70. PubMed ID: 15049605
[No Abstract] [Full Text] [Related]
13. Efficacy of acitretin in severe psoriasis.
Geiger JM
Skin Therapy Lett; 2003; 8(4):1-3, 7. PubMed ID: 12858231
[TBL] [Abstract][Full Text] [Related]
14. Erythroderma in a patient taking acitretin for plaque psoriasis.
Ahdout J; Mandel H; Chiu M
J Drugs Dermatol; 2008 Apr; 7(4):391-4. PubMed ID: 18459522
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of acitretin and commercial tanning bed therapy for psoriasis.
Carlin CS; Callis KP; Krueger GG
Arch Dermatol; 2003 Apr; 139(4):436-42. PubMed ID: 12707089
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
